CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,000 | -26.1% | 17,069 | +13.2% | 0.00% | – |
| Q2 2023 | $157,000 | +72.5% | 15,085 | +15.7% | 0.00% | – |
| Q1 2023 | $91,000 | +313.6% | 13,043 | +248.5% | 0.00% | – |
| Q4 2022 | $22,000 | -74.7% | 3,743 | -66.3% | 0.00% | – |
| Q3 2022 | $87,000 | -34.6% | 11,119 | +13.0% | 0.00% | – |
| Q2 2022 | $133,000 | -45.3% | 9,839 | -20.6% | 0.00% | – |
| Q1 2022 | $243,000 | -46.4% | 12,399 | -6.2% | 0.00% | – |
| Q4 2021 | $453,000 | +33.6% | 13,217 | +114.0% | 0.00% | – |
| Q3 2021 | $339,000 | +153.0% | 6,176 | +237.9% | 0.00% | – |
| Q2 2021 | $134,000 | +191.3% | 1,828 | +260.6% | 0.00% | – |
| Q1 2021 | $46,000 | -83.6% | 507 | -85.3% | 0.00% | – |
| Q4 2020 | $280,000 | +76.1% | 3,441 | +1.2% | 0.00% | – |
| Q3 2020 | $159,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |